1529 related articles for article (PubMed ID: 17903393)
1. A systematic review and economic model of the clinical effectiveness and cost-effectiveness of interventions for preventing relapse in people with bipolar disorder.
Soares-Weiser K; Bravo Vergel Y; Beynon S; Dunn G; Barbieri M; Duffy S; Geddes J; Gilbody S; Palmer S; Woolacott N
Health Technol Assess; 2007 Oct; 11(39):iii-iv, ix-206. PubMed ID: 17903393
[TBL] [Abstract][Full Text] [Related]
2. [Antipsychotics in bipolar disorders].
Vacheron-Trystram MN; Braitman A; Cheref S; Auffray L
Encephale; 2004; 30(5):417-24. PubMed ID: 15627046
[TBL] [Abstract][Full Text] [Related]
3. A rapid and systematic review and economic evaluation of the clinical and cost-effectiveness of newer drugs for treatment of mania associated with bipolar affective disorder.
Bridle C; Palmer S; Bagnall AM; Darba J; Duffy S; Sculpher M; Riemsma R
Health Technol Assess; 2004 May; 8(19):iii-iv, 1-187. PubMed ID: 15147609
[TBL] [Abstract][Full Text] [Related]
4. The cost-effectiveness of lamotrigine in the maintenance treatment of adults with bipolar I disorder.
Calvert NW; Burch SP; Fu AZ; Reeves P; Thompson TR
J Manag Care Pharm; 2006 May; 12(4):322-30. PubMed ID: 16792438
[TBL] [Abstract][Full Text] [Related]
5. Valproic acid, valproate and divalproex in the maintenance treatment of bipolar disorder.
Cipriani A; Reid K; Young AH; Macritchie K; Geddes J
Cochrane Database Syst Rev; 2013 Oct; 2013(10):CD003196. PubMed ID: 24132760
[TBL] [Abstract][Full Text] [Related]
6. Cost effectiveness of adjunctive quetiapine fumarate extended-release tablets with mood stabilizers in the maintenance treatment of bipolar I disorder.
Woodward TC; Tafesse E; Quon P; Lazarus A
Pharmacoeconomics; 2010; 28(9):751-64. PubMed ID: 20623994
[TBL] [Abstract][Full Text] [Related]
7. Polytherapy in bipolar disorder.
Lin D; Mok H; Yatham LN
CNS Drugs; 2006; 20(1):29-42. PubMed ID: 16396522
[TBL] [Abstract][Full Text] [Related]
8. Pharmacological interventions for the prevention of relapse in bipolar disorder: a systematic review of controlled trials.
Beynon S; Soares-Weiser K; Woolacott N; Duffy S; Geddes JR
J Psychopharmacol; 2009 Jul; 23(5):574-91. PubMed ID: 18635701
[TBL] [Abstract][Full Text] [Related]
9. Olanzapine in long-term treatment for bipolar disorder.
Cipriani A; Rendell JM; Geddes J
Cochrane Database Syst Rev; 2009 Jan; (1):CD004367. PubMed ID: 19160237
[TBL] [Abstract][Full Text] [Related]
10. Mood stabilizers and/or antipsychotics for bipolar disorder in the maintenance phase: a systematic review and network meta-analysis of randomized controlled trials.
Kishi T; Ikuta T; Matsuda Y; Sakuma K; Okuya M; Mishima K; Iwata N
Mol Psychiatry; 2021 Aug; 26(8):4146-4157. PubMed ID: 33177610
[TBL] [Abstract][Full Text] [Related]
11. Effectiveness of mood stabilizers and antipsychotics in the maintenance phase of bipolar disorder: a systematic review of randomized controlled trials.
Smith LA; Cornelius V; Warnock A; Bell A; Young AH
Bipolar Disord; 2007 Jun; 9(4):394-412. PubMed ID: 17547586
[TBL] [Abstract][Full Text] [Related]
12. Olanzapine in the long-term treatment of bipolar disorder: a systematic review and meta-analysis.
Cipriani A; Rendell J; Geddes JR
J Psychopharmacol; 2010 Dec; 24(12):1729-38. PubMed ID: 19828571
[TBL] [Abstract][Full Text] [Related]
13. Valproic acid, valproate and divalproex in the maintenance treatment of bipolar disorder.
Macritchie KA; Geddes JR; Scott J; Haslam DR; Goodwin GM
Cochrane Database Syst Rev; 2001; (3):CD003196. PubMed ID: 11687047
[TBL] [Abstract][Full Text] [Related]
14. Lithium or an atypical antipsychotic drug in the management of treatment-resistant depression: a systematic review and economic evaluation.
Edwards SJ; Hamilton V; Nherera L; Trevor N
Health Technol Assess; 2013 Nov; 17(54):1-190. PubMed ID: 24284258
[TBL] [Abstract][Full Text] [Related]
15. Lithium for acute mania.
McKnight RF; de La Motte de Broöns de Vauvert SJGN; Chesney E; Amit BH; Geddes J; Cipriani A
Cochrane Database Syst Rev; 2019 Jun; 6(6):CD004048. PubMed ID: 31152444
[TBL] [Abstract][Full Text] [Related]
16. A clinical review of aripiprazole in bipolar depression and maintenance therapy of bipolar disorder.
Yatham LN
J Affect Disord; 2011 Jan; 128 Suppl 1():S21-8. PubMed ID: 21220077
[TBL] [Abstract][Full Text] [Related]
17. Efficacy of pharmacotherapy in bipolar disorder: a report by the WPA section on pharmacopsychiatry.
Fountoulakis KN; Kasper S; Andreassen O; Blier P; Okasha A; Severus E; Versiani M; Tandon R; Möller HJ; Vieta E
Eur Arch Psychiatry Clin Neurosci; 2012 Jun; 262 Suppl 1():1-48. PubMed ID: 22622948
[TBL] [Abstract][Full Text] [Related]
18. Olanzapine: new indication. Prevention of bipolar disorder: unconvincing trials.
Prescrire Int; 2005 Aug; 14(78):140-2. PubMed ID: 16106596
[TBL] [Abstract][Full Text] [Related]
19. [Treatment of acute bipolar disorder. Intriguing balancing act between mania and depression].
Grunze H; Dittmann S
MMW Fortschr Med; 2003 May; 145 Suppl 2():27-30. PubMed ID: 14579481
[TBL] [Abstract][Full Text] [Related]
20. Lamotrigine compared to placebo and other agents with antidepressant activity in patients with unipolar and bipolar depression: a comprehensive meta-analysis of efficacy and safety outcomes in short-term trials.
Solmi M; Veronese N; Zaninotto L; van der Loos ML; Gao K; Schaffer A; Reis C; Normann C; Anghelescu IG; Correll CU
CNS Spectr; 2016 Oct; 21(5):403-418. PubMed ID: 27686028
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
